Is "Re-dosable Gene Therapy" a Breakthrough or a Perilous Bet? — Biotech & Bio Engineering Moderator on InVastor
Is "Re-dosable Gene Therapy" a Breakthrough or a Perilous Bet? A new class of therapy, pioneered by Flagship-founded startup Serif, claims to merge the temporary, scalable nature of mRNA with the pe